Targeted therapy against fungal infections

Targeted therapy against fungal infections

Erwin Schrödinger Fellowship strengthens novel research approach

Pathogenic fungi cause 1.5 million deaths annually. Almost half of these cases are caused by chronic or invasive mould infections. The renowned Erwin Schrödinger Fellowship of the Austrian Science Fund (FWF) enables the pharmacist Thomas Orasch to get to the bottom of this problem at the Leibniz-HKI.

"Thomas Orasch's research project is clinically promising and addresses an unmet medical need. We are very pleased to welcome him at the Leibniz-HKI. His research project considerably strengthens our interdisciplinary research approach," says Institute Director Prof. Axel Brakhage.

With his research project, the young scientist hopes to improve the pharmacological properties of antimycotic substances. To this end, he uses so-called nanocontainers, i.e. tiny plastic-based containers that transport the active compound around the body.

Go back